Sammy Karam - Aug 17, 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
SENIOR VICE PRESIDENT
Signature
/s/ Sammy Karam by Jessica H. Paik, Attorney-in-Fact
Stock symbol
ABT
Transactions as of
Aug 17, 2021
Transactions value $
-$392,800
Form type
4
Date filed
8/19/2021, 06:29 PM
Previous filing
Aug 5, 2021
Next filing
Dec 28, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $607K +8K +34.89% $75.90 30.9K Aug 17, 2021 Direct
transaction ABT Common shares without par value Sale -$1M -8K -25.87% $125.00 22.9K Aug 17, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -8K -12.31% $0.00 57K Aug 17, 2021 Common Shares 8K $75.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).